Product Description: EZH2-IN-13 is a potent EZH2 inhibitor, for details please refer to compound 73 in patent WO2017139404. EZH2-IN-13 can be used to study cancers or precancerous lesions associated with EZH2 activity[1].
Applications: Cancer-programmed cell death
Formula: C34H45N5O3
References: [1]Jesse Smith, et al. Methods of treating cancer. WO2017139404.